NIGHTHAWK BIOSCIENCES INC (NHWK) Stock Price, Forecast & Analysis
USA - NYSEARCA:NHWK - US42237K4094 - Common Stock
NHWK Key Statistics, Chart & Performance
The current stock price of NHWK is 0.4135 USD. In the past month the price decreased by -8.05%. In the past year, price decreased by -60.24%.
NHWK Latest News, Press Relases and Analysis
NHWK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.28 | 405.34B | ||
| AMGN | AMGEN INC | 15.37 | 180.93B | ||
| GILD | GILEAD SCIENCES INC | 15.26 | 155.09B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.33 | 108.28B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.37 | 78.11B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 874.1 | 58.43B | ||
| INSM | INSMED INC | N/A | 42.20B | ||
| NTRA | NATERA INC | N/A | 30.96B | ||
| BIIB | BIOGEN INC | 10.05 | 24.66B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.99 | 21.47B | ||
| INCY | INCYTE CORP | 15.85 | 19.87B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.06B |
Related stock screener links
About NHWK
Company Profile
NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 77 full-time employees. The company went IPO on 2013-07-24. Scorpius offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its clinical biomanufacturing capabilities include cGMP Mammalian Cell Culture and cGMP Microbial Fermentation. Its process development includes mammalian cell culture development, cell therapy development, microbial fermentation development, downstream process development and formulation development. The company also offers bioanalytical services, analytical methods development, pre-clinical and product development services, CMC analytical support services, bioassays and analytical technologies.
Company Info
NIGHTHAWK BIOSCIENCES INC
627 Davis Drive, Suite 300
Morrisville NORTH CAROLINA US
Employees: 77
Phone: 19192407133
NIGHTHAWK BIOSCIENCES INC / NHWK FAQ
What does NIGHTHAWK BIOSCIENCES INC do?
NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Morrisville, North Carolina and currently employs 77 full-time employees. The company went IPO on 2013-07-24. Scorpius offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its clinical biomanufacturing capabilities include cGMP Mammalian Cell Culture and cGMP Microbial Fermentation. Its process development includes mammalian cell culture development, cell therapy development, microbial fermentation development, downstream process development and formulation development. The company also offers bioanalytical services, analytical methods development, pre-clinical and product development services, CMC analytical support services, bioassays and analytical technologies.
Can you provide the latest stock price for NIGHTHAWK BIOSCIENCES INC?
The current stock price of NHWK is 0.4135 USD. The price increased by 8.96% in the last trading session.
Does NIGHTHAWK BIOSCIENCES INC pay dividends?
NHWK does not pay a dividend.
What is the ChartMill technical and fundamental rating of NHWK stock?
NHWK has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the expected growth for NHWK stock?
The Revenue of NIGHTHAWK BIOSCIENCES INC (NHWK) is expected to decline by -28.99% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for NHWK stock?
NIGHTHAWK BIOSCIENCES INC (NHWK) will report earnings on 2024-03-29, after the market close.
Who owns NIGHTHAWK BIOSCIENCES INC?
You can find the ownership structure of NIGHTHAWK BIOSCIENCES INC (NHWK) on the Ownership tab.
NHWK Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NHWK. When comparing the yearly performance of all stocks, NHWK is a bad performer in the overall market: 90.35% of all stocks are doing better.
NHWK Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NHWK. NHWK has a bad profitability rating. Also its financial health evaluation is rather negative.
NHWK Financial Highlights
Over the last trailing twelve months NHWK reported a non-GAAP Earnings per Share(EPS) of -1.98. The EPS decreased by -21.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.32% | ||
| ROE | -143.11% | ||
| Debt/Equity | 0.25 |
NHWK Forecast & Estimates
6 analysts have analysed NHWK and the average price target is 10.2 USD. This implies a price increase of 2366.75% is expected in the next year compared to the current price of 0.4135.
For the next year, analysts expect an EPS growth of -16.18% and a revenue growth -28.99% for NHWK